3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Unknown
1
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Classical hematology
1
Conditions
Polycystic Ovary Syndrome
3
Osteoporosis
2
Prostatic Neoplasms
1
Hot Flashes
1
Coronary Disease
1
Cardiovascular Diseases
1
Breast Neoplasms
1
Anemia
1
Interventions
Docetaxel
21
Radiosurgery
19
Radiotherapy
17
Androgen Antagonists
14
Leuprolide
11
Goserelin
11
bicalutamide
9
enzalutamide
8
Surveys and Questionnaires
8
Prednisone
8
Brachytherapy
8
Blood Specimen Collection
8
Abiraterone Acetate
8
acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide
7
Radiotherapy, Intensity-Modulated
7
Multiparametric Magnetic Resonance Imaging
7
Gonadotropin-Releasing Hormone
7
Triptorelin Pamoate
6
pembrolizumab
4
cabazitaxel
4
abiraterone
4
Standard of Care
4
Positron Emission Tomography Computed Tomography
4
Metformin
4
Heavy Ion Radiotherapy
4
Exercise
4
Estramustine
4
luprolide acetate gel depot
3
darolutamide
3
Watchful Waiting
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Prostatic Neoplasms
×
Estradiol
×
Clear all
NCT00303784
2020-11-27
PATCH
University College, London
Phase 3
Unknown
2,200 enrolled